|
| |
BioEmail targeted email Neurodegenerative diseases List
Neurodegenerative diseases email list
Neuroscientists, clinicians and commercial scientists working on
neurological diseases such as Altzheimer’s and Parkinson’s.
Current number on list : 11,025
Regional Breakdown Percentage
-
Europe 40.6%
-
USA 31.7%
-
Rest of World 27.7%
Keywords:
• Neurodegenerative
• Altzheimer's
• Parkinson's
• Dementia
• Huntington’s
• Neurodegeneration
Additional terms to consider to expand the list where appropriate:
• Neurone
• Neuroscience
• Stroke
Top Countries
-
USA 31.7%
-
UK 6.9%
-
Japan 5.8%
-
Germany 5.3%
-
Italy 4.8%
-
Canada 3.5%
-
France 3.1%
-
Spain 2.2%
Sector Distribution
-
Academic (.ac., .edu etc.) 56.7%
-
Commercial (.com, .co.uk etc.) 4.4%
-
Government (.gov etc.) 1.1%
-
Other (Mainly country TLDs eg. .de, .jp
etc.) 37.8%
Example Job Titles:
• Professor
• Scientific Director
• Researcher
• Dow Chair and Director Neurobiology
• Scientist, Neuroscience Drug Discovery, Bristol-Myers Squibb
Pharmaceutical Research Institute
• Principle Investigator
Sample Grantholders
xxx@stanford.edu
Giant axonal neuropathy.
xxx@mail.med.upenn.edu
Pesticide Exposure Exacerbates {alpha}-Synucleinopathy in an A53T Transgenic
Mouse Model.
xxx@nas.edu Update
on the NAS-NRC Twin Registry.
xxx@duke.edu Duke
Twins Study of Memory in Aging in the NAS-NRC Twin Registry.
xxx@poczta.onet.pl
Myoelectrical activity of small intestine in rats with experimental
Parkinson's disease.
xxx@son.umsmed.edu
The home health nurse's role in geriatric assessment of three dimensions:
depression
xxx@psych.imed.uni-erlangen.de Daytime
impairment and neurodegeneration in OSAS.
xxx@northwestern.edu
Abeta oligomer-induced aberrations in synapse composition
xxx@zg.htnet.hr
Association of rural life setting and poorer quality of life in Parkinson's
disease patients: a cross-sectional study in Croatia.
xxx@brc.aphp.fr
Relevance of 10-min delayed recall in dementia screening.
xxx@neuro.au.dk
Chronic subthalamic high-frequency deep brain stimulation in Parkinson's
disease--a histopathological study.
xxx@stanford.edu
Giant axonal neuropathy.
Sample Published Authors
xxx@umich.edu
Michigan Parkinson's Disease Clinical Center
xxx@downstate.edu
Parkinson's Dis. Neuroprotection:Brooklyn Clinical Ctr.
xxx@mssm.edu ROLE
OF PROTEASOMAL DYSFUNCTION IN PARKINSON'S DISEASE
xxx@med.unc.edu
Role of Mammalian PITP Beta in Neurodegenerative Disease
xxx@lamar.colostate.edu
ADF-Actin Rods in Neurodegenerative Diseases
xxx@uky.edu Gene
Therapy, Neural Grafts & Parkinson's Disease
xxx@np.awing.upmc.edu
Transcriptional Responses in Neurodegenerative Diseases
xxx@rush.edu
Prenatal Endotoxin as a Model of Parkinson's Disease
xxx@gladstone.ucsf.edu
Role of ApoE4 Domain Interaction in Neurodegeneration
Example companies
• Reliance Life Sciences
• Merck
• Johnson and Johnson
• Oxford Biomedica
• RenaSci
• Astra Zeneca
Call us to discuss your specific requirements:
Peter Barfoot . Tel: (+44) 1300 321501
From USA: 011 44 1300 321 501
Peter.Barfoot@bioportfolio.com
http://www.bioportfolio.com/advertis/bioemail.htm
* Our database is constantly being updated and edited. Newly published
authors and grant applicants are added daily and emails which become disused
are constantly purged from our system.
| |
|